HIV 1 News and Research

RSS

Scientists reverse HIV latency, take major scientific step toward curative therapies

Approximately 38 million people are infected with HIV worldwide, about 1.1 million people in the United States. Currently, people with HIV take antiretroviral therapy (ART), which can suppress HIV to undetectable levels in blood, but the virus persists throughout the body in latently infected resting CD4+ T cells.

22 Jan 2020

'Lay counselors' help reduce trauma-related symptoms among children orphaned in Africa

A first-of-its-kind clinical trial involving more than 600 children in Kenya and Tanzania, in which community members were trained to deliver mental health treatment, showed improvement in participants' trauma-related symptoms up to a year after receiving therapy, new research shows.

22 Jan 2020

Community-based wellness instructors can provide tailored wellness care to older adults

Community-based wellness instructors can provide tailored wellness care to older adults, according to researchers at Columbia University Mailman School of Public Health.

22 Jan 2020

Antiviral compound from banana plants shows potential for clinical use against influenza

What keeps most infectious disease researchers up at night aren't infamous viruses like Ebola. Instead, influenza, commonly known as the flu, continues to be a clear and present danger to humanity.

21 Jan 2020

New HIV infections among gay and bisexual men in the UK fall by 71 percent

The Human Immunodeficiency Virus (HIV) is a highly contagious infection usually transmitted through body fluids during sexual contact, blood transfusion, during pregnancy, delivery, and breastfeeding through breast milk. Worldwide, there were about 37.9 million people across the globe with HIV in 2018, and approximately 1.7 million people became newly infected across the globe in 2018 alone.

16 Jan 2020

"Jumping genes" within eggs determine their survival

Females are born with a finite supply of eggs and with age the genetic quality of the eggs decline say researchers from Carnegie Institute. The study from researchers Marla Tharp, Safia Malki, and Alex Bortvin was published in the latest issue of Nature Communications. The study was titled, “Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity.”

16 Jan 2020

Research shows how the body tries to eliminate egg cells of poorest quality

A woman's supply of eggs is finite, so it is crucial that the quality of their genetic material is ensured. New work from Carnegie's Marla Tharp, Safia Malki, and Alex Bortvin elucidates a mechanism by which, even before birth, the body tries to eliminate egg cells of the poorest quality.

16 Jan 2020

HIV 'hotspots' do not necessarily fuel the epidemic

Areas of high HIV prevalence, known as 'hotspots', do not necessarily fuel the epidemic in the wider population, say researchers.

14 Jan 2020

Horizon Discovery to offer novel base editing technology for clinical research

Horizon Discovery today announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

From Revvity 14 Jan 2020

A New Discovery about MAIT Cells Sheds Light on Early-Phase HIV Infection

Researchers at the Karolinska Institutet, Sweden, have made an important discovery about a poorly understood group of immune cells (mucosa-associated invariant T [MAIT]cells) that could improve understanding of what happens during the initial stages of HIV infection.

14 Jan 2020

Study delineates the dynamic MAIT cell response during acute HIV infection

In a new study published in Nature Communications, researchers at Karolinska Institutet show that MAIT cells (mucosa-associated invariant T cells), part of the human immune system, respond with dynamic activity and reprogramming of gene expression during the initial phase of HIV infection.

14 Jan 2020

Lymphopenia may hint a higher risk of future illness, death

Lymphopenia, which indicates lower levels of lymphocytes in the blood, has been tied to a higher risk of future illness and death, a new study found.

13 Jan 2020

Researchers provide first robust cell culture model for hepatitis E virus

Even though hepatitis E causes over three million infections and about 70,000 deaths each year, the virus has been little studied as yet.

13 Jan 2020

Rejuvenating the BCG Vaccine

A new primate study published in the journal Nature in January 2020, reports that the almost century-old BCG vaccine against tuberculosis, may be used differently to achieve better protection against lung tuberculosis. While more work remains to be carried out before the findings can be accepted as the basis for clinical practice, they are extremely promising in the fight against this killer.

10 Jan 2020

Smoking dormant HIV virus out into the open to develop a cure

Ever since antiretroviral treatments against HIV infection were introduced in 1996, scientists have eagerly been hunting for a cure for the disease.

9 Jan 2020

Timing is key: preventing infant SHIV infection by PEP

Researchers tested methods to prevent development of SHIV, an infection similar to HIV, in infant macaque monkeys.

9 Jan 2020

Researchers identify synergistic cellular pathways that considerably amplify lifespan

Scientists at the MDI Biological Laboratory, in collaboration with scientists from the Buck Institute for Research on Aging in Novato, Calif., and Nanjing University in China, have identified synergistic cellular pathways for longevity that amplify lifespan fivefold in C. elegans, a nematode worm used as a model in aging research.

9 Jan 2020

FSU discovery could open the door to new treatment options for HIV, hepatitis B

A discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 36 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B.

8 Jan 2020

Intervention for hospitalized HIV patients reduces infection rates and increases engagement in care

Providing multidisciplinary team consults for HIV patients while they are hospitalized to help address social and medical barriers reduces future infection rates and boosts participation in follow-up care, results from a study on how to reengage patients show.

7 Jan 2020

New Yorkers are being treated sooner after HIV infection, study shows

The most effective way to reduce HIV-related deaths and prevent onward transmission is to diagnose and treat all persons as soon as possible after HIV infection. According to a study published in Clinical Infectious Diseases, New Yorkers living with HIV are being treated sooner after infection.

7 Jan 2020